Fred Alger Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-104,851
| Closed | -$5.96M | – | 554 |
|
|
2021
Q2 | $5.96M | Buy |
104,851
+83,037
| +381% | +$4.72M | 0.01% | 282 |
|
|
2021
Q1 | $1.63M | Sell |
21,814
-20,016
| -48% | -$1.5M | ﹤0.01% | 354 |
|
|
2020
Q4 | $3.62M | Sell |
41,830
-105,738
| -72% | -$9.15M | 0.01% | 296 |
|
|
2020
Q3 | $9.02M | Buy |
+147,568
| New | +$9.02M | 0.03% | 211 |
|
|
2020
Q2 | – | Sell |
-12,000
| Closed | -$345K | – | 585 |
|
|
2020
Q1 | $345K | Sell |
12,000
-3,000
| -20% | -$86.3K | ﹤0.01% | 374 |
|
|
2019
Q4 | $1.08M | Buy |
15,000
+7,500
| +100% | +$542K | ﹤0.01% | 332 |
|
|
2019
Q3 | $1.05M | Buy |
7,500
+500
| +7% | +$70.1K | ﹤0.01% | 328 |
|
|
2019
Q2 | $1.28M | Buy |
7,000
+1,000
| +17% | +$183K | ﹤0.01% | 322 |
|
|
2019
Q1 | $954K | Buy |
+6,000
| New | +$954K | ﹤0.01% | 338 |
|
|
2018
Q4 | – | Sell |
-19,989
| Closed | -$2.82M | – | 566 |
|
|
2018
Q3 | $2.82M | Sell |
19,989
-3,471
| -15% | -$490K | 0.01% | 264 |
|
|
2018
Q2 | $3.67M | Buy |
23,460
+4,276
| +22% | +$669K | 0.02% | 245 |
|
|
2018
Q1 | $3.09M | Buy |
19,184
+12,684
| +195% | +$2.04M | 0.01% | 263 |
|
|
2017
Q4 | $1.07M | Sell |
6,500
-3,509
| -35% | -$578K | ﹤0.01% | 333 |
|
|
2017
Q3 | $624K | Buy |
10,009
+1,000
| +11% | +$62.3K | ﹤0.01% | 347 |
|
|
2017
Q2 | $717K | Buy |
9,009
+1,009
| +13% | +$80.3K | ﹤0.01% | 350 |
|
|
2017
Q1 | $569K | Buy |
+8,000
| New | +$569K | ﹤0.01% | 356 |
|